Cancer Rop
IPO- Business Model
- B2B
- Website
- cancerrop.com
About
CancerROP is a molecular diagnostics company specializing in DNA analysis chips, antibody rapid test kits, and next-generation sequencing (NGS) services for cancer detection and research. The company develops and commercializes diagnostic products that leverage DNA chip technology to enable precise cancer-related biomarker analysis, positioning itself as a provider of both diagnostic products and laboratory services. As a leading molecular diagnostic products and service provider, CancerROP serves clinical, research, and pharmaceutical customers requiring high-sensitivity genomic assays for oncology applications.
Summary
Cancer Rop is a Biotech company.
Funding History
Nov 2015
Similar Companies
China's leading blood products manufacturer

IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...

Specialty pharmaceutical company
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/cancer-rop"><img src="https://indexed.vc/api/badge/company/cancer-rop" alt="Cancer Rop on Indexed.vc" width="260" height="76" /></a>